Science
Mechanism of Action
While its complete mechanism is still under investigation, topical lithium gluconate exerts its action through both anti-inflammatory and antifungal pathways. It is believed to inhibit pro-inflammatory cytokines and suppress the proliferation of Malassezia yeast, a known contributor to seborrheic dermatitis. Studies have shown that at concentrations around 5 mM, it increases the production and release of the anti-inflammatory cytokine IL10 and concurrently reduces the expression of Toll-like receptors 2 and 4 (TLR2 and TLR4) in keratinocytes. Furthermore, lithium influences various enzymatic activities and modulates immune cells like neutrophils and T lymphocytes, contributing to its overall anti-inflammatory effect.
Research
Clinical Evidence
High confidence8%
Key findings
- 01 Multiple clinical trials demonstrated that an 8% topical lithium gluconate gel was significantly more effective than both placebo and 2% ketoconazole foaming gel, leading to complete remission of seborrheic dermatitis (disappearance of erythema and desquamation) within two months of treatment.
- 02 In vitro studies on differentiated keratinocytes showed that 5 mM lithium gluconate enhanced the expression and secretion of the anti-inflammatory cytokine IL10, while also significantly decreasing the expression of Toll-like receptors 2 (TLR2) and 4 (TLR4).
Transparency
Dusting Analysis
The Formula
Formulation
Stability
Lithium D-Gluconate maintains stability and mildness in cosmetic-grade preparations. For industrial production, the pH of the reaction mixture is typically maintained between 3 and 7 for optimal yield and purity. It should be stored in original, tight-closed containers, in a dry, ventilated place at room temperature, away from light and heating. Under specific conditions, it can decompose into lithium oxide and gluconic acid.
Safety
Safety Profile
Topical application of lithium gluconate at 8% has been safely used in clinical studies, exhibiting minimal systemic absorption. Reported adverse events were typically mild, localized cutaneous reactions such as a transient burning sensation, redness (erythema), and itching (pruritus). While Lithium Gluconate specifically is not assessed by the Cosmetic Ingredient Review (CIR) Expert Panel, the broader group of Gluconic Acid and its derivatives, which includes Lithium Gluconate, were deemed low priority for further assessment, showing no evidence of skin or eye irritation, skin sensitization, or mutagenicity/reproductive toxicity. However, it is not advised for use during the first trimester of pregnancy. Concerns regarding neurotoxicity and systemic toxicity are primarily associated with systemic lithium administration, not the low absorption profile of topical applications.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Lithium gluconate is a valuable active ingredient for managing inflammatory skin conditions like seborrheic dermatitis due to its proven anti-inflammatory and antifungal actions with a favorable topical safety profile.
Related
Similar Ingredients
Finding similar ingredients…